Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
1.270
+0.130 (11.40%)
At close: Jan 21, 2025, 4:00 PM
1.100
-0.170 (-13.39%)
Pre-market: Jan 22, 2025, 6:37 AM EST
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $55.83 million as of January 22, 2025. Its market cap has increased by 179.83% in one year.
Market Cap
55.83M
Enterprise Value
2.98M
1-Year Change
179.83%
Ranking
Category
Stock Price
$1.27
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $55.83M, a decrease of -86.92%. That is a compound annual growth rate of -46.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 55.83M | 32.98% |
| Dec 31, 2024 | 41.98M | 177.26% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 341.33B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |